top of page
News, Events and Updates
Search
Jun 22, 2016
Anavex Announces U.S. FDA Orphan Drug Designation for ANAVEX 2-73 for Treatment of Infantile Spasms
Jun 15, 2016
2016 Rett Syndrome Symposium
Jun 11, 2016
Sigma-1 Receptor Agonists as Potential Treatment Options for Autism Spectrum Disorders
Jun 11, 2016
AAT Presentation
Jun 6, 2016
Anavex Announces Positive Preclinical Results w/ ANAVEX 2-73 in Fragile X — Autism-Related Disorders
May 20, 2016
Anavex Announces U.S. FDA Orphan Drug Designation to ANAVEX 2-73 for the Treatment of Rett Syndrome
May 18, 2016
Anavex Announces Positive Preclinical Data for ANAVEX 2-73 in Infantile Spasms
May 11, 2016
Anavex Reports Fiscal Second Quarter 2016 Financial Results
May 3, 2016
Speaker Session: BIO 2016 International Convention
Apr 8, 2016
U.S. FDA Grants Orphan Drug Designation to ANAVEX 3-71 for the Treatment of Frontotemporal Dementia
Apr 6, 2016
33rd Camerino-Cyprus Symposium
27
28
29
30
31
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
